GL1X · GenesisL1 explorer

MolNFT v1 · #142688 · protein

Crystal structure of PDE5 in complex with inhibitor LW1805

6ACB · Cgmp-specific 3',5'-cyclic phosphodiesterase: “Crystal structure of PDE5 in complex with inhibitor LW1805”. X-ray diffraction, 4 ligands (9T9, ZN, MG), 2 pockets (best druggability 0.67). MolNFT v1 #142688 on GenesisL1: 3D…

PDB
6ACB
Type
protein
Length
308 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cgmp-specific 3',5'-cyclic phosphodiesterase
EC
3.1.4.35
UniProt
O76074
Ligands
9T9, ZN, MG, SO4
Pockets
2 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 67% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACgmp-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35)protein30867% helix, 0% strandO76074

Ligands and binding sites

  • 9T9 · 3-[(2H-1,3-benzodioxol-5-yl)methyl]-8-fluoro-6-{[2-(4-methylpiperazin-1-yl)ethyl]amino}-1-(1,3-thiazol-2-yl)[1]benzopyrano[2,3-c]pyrrol-9(2H)-one · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • MG · Magnesium ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14160.670.7938SO4, MG, 9T9
2740.370.7818empty

Compared structures

  • 6ACB · Crystal structure of PDE5 in complex with inhibitor LW1805 · the same entry in another collection · chain A against A, TM-score 1.00
  • O76074 · AlphaFold monomer V2.0 prediction for cgmp-specific 3',5'-cyclic phosphodiesterase… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.